Dyax

Sector:
Healthcare

Location:
Cambridge, MA

Year Funded:
1998

Status:
IPO

Website:
www.dyax.com


Summary:
Dyax is a fully-integrated biopharmaceutical company focused on discovering, developing and commercializing novel biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications. Dyax utilizes its proprietary drug discovery technology to identify antibody, small protein and peptide compounds for clinical development.